#Spain #Barcelona #Probiotics #Vitafoods #BioFlag

BioFlag's Innovations at Vitafoods Europe 2025

In an exciting showcase at Vitafoods Europe 2025, BioFlag, a significant player in the probiotic market based in China, has unveiled an impressive range of scientifically validated probiotic solutions that have attracted the attention of global media. The event, held in Barcelona, Spain, emphasized the company's commitment to advancing health and nutrition through high-quality probiotics.

Among the highlights of BioFlag's presentation were advanced probiotic strains and ready-to-use probiotic products targeting various health aspects. These included solutions for gut health, immune regulation, metabolism, weight management, oral health, and emotional wellness, all supported by clinical research. The products were tailored to meet stringent European and American standards, showcasing BioFlag's dedication to quality and efficacy.

Key Innovations

BioFlag introduced several noteworthy innovations at the expo, including:
1. Bifidobacterium animalis subsp. lactis BL-99: This strain, derived from the maternal and infant probiotic strain library, holds 12 Chinese patents regarding gut health, immune regulation, and bone health. It is commonly used in infant formulas, yogurts, and dietary supplements.
2. Lactobacillus paracasei K56: Isolated from healthy Chinese infants' intestines, this strain has been clinically proven to reduce fat deposits, visceral fat, and waist circumference, with 9 Chinese patents and confirmation from 12 published research studies supporting its efficacy.
3. Bifidobacterium animalis subsp. lactis CP-9: This strain, which originates in the breast milk of healthy Chinese mothers, is patented in China for its role in combating obesity and treating or preventing jaundice.

BioFlag's comprehensive capabilities in the probiotic industry include a proprietary library of over 3,500 strains and more than 30 functional screening platforms. The company holds over 130 patents and boasts more than 100 published scientific papers. Their stringent adherence to international standards is further underscored by certifications like GMP, FSSC22000, and HALAL. BioFlag’s capacity to produce diverse formulations, including powders, tablets, and capsules, highlights its versatility in addressing various health needs.

During the exhibition, BioFlag engaged in discussions with numerous enterprises and institutions from Europe, North America, and beyond, exploring potential collaborations. A company representative expressed, "With nearly two decades of experience in functional probiotics, we continue to pursue innovation in R&D and the development of intelligent production systems to provide outstanding health solutions to our global customers."

For more details about BioFlag’s offerings and innovations, please visit their official website at BioFlag.



This presentation at Vitafoods Europe not only enhances BioFlag's visibility in the global market but also emphasizes the growing importance of probiotics in maintaining health and well-being in consumers of all ages.